← Master Registry

Published peptide research references

Melittin

Governed registry record

4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. Melittin-Based Nano-Delivery Systems for Cancer Therapy.

    DOI: 10.3390/biom12010118

    Source identity and connection checked by Codex (AI).

  2. Melittin-incorporated nanomedicines for enhanced cancer immunotherapy.

    DOI: 10.1016/j.jconrel.2024.08.047

    Source identity and connection checked by Codex (AI).

  3. Melittin: from honeybees to superbugs.

    DOI: 10.1007/s00253-019-09698-y

    Source identity and connection checked by Codex (AI).

  4. MnO(2)-melittin nanoparticles serve as an effective anti-tumor immunotherapy by enhancing systemic immune response.

    DOI: 10.1016/j.biomaterials.2022.121706

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Duan X
  • Zou H
  • Yang J
  • Liu S
  • Xu T
  • Ding J
  • Wang A
  • Zheng Y
  • Zhu W
  • Yang L
  • Yang Y
  • Peng J
  • Tang S
  • Zhou L
  • He H
  • Cui L
  • Ren Z
  • Tai Y
  • Xie Z
  • Cao Y
  • Meng D
  • Liu Q
  • Wu Y
  • Jiang J
  • Zhou X
  • Memariani H
  • Memariani M
  • Shahidi-Dadras M
  • Nasiri S
  • Akhavan MM
  • Moravvej H